Right To Try Individualized Treatments.

HB 1029 allows patients with life-threatening or severely debilitating illnesses to access custom-made investigational drugs, biological products, or devices that are tailored to their specific genetic profiles. To qualify, a patient must consult with a treating physician, confirm that standard FDA-approved treatments are unlikely to help, and provide written informed consent acknowledging the risks and potential costs. The bill permits manufacturers to offer these treatments for free or at the patient's expense while explicitly stating that health insurance plans are not required to cover these costs. Additionally, the legislation protects doctors from disciplinary action for recommending such treatments and ensures that a patient's heirs are not held financially responsible for any outstanding debts related to the therapy if the patient passes away.